Preventive Administration of Ursodeoxycholic Acid after Liver Transplantation for Primary Biliary Cholangitis Prevents Disease Recurrence and Prolongs Graft Survival - Sorbonne Université Access content directly
Journal Articles Journal of Hepatology Year : 2020

Preventive Administration of Ursodeoxycholic Acid after Liver Transplantation for Primary Biliary Cholangitis Prevents Disease Recurrence and Prolongs Graft Survival

Christophe Corpechot
Olivier Chazouillères
  • Function : Author
Pierre Belnou
  • Function : Author
Aldo J Montano-Loza
  • Function : Author
Andrew L Mason
  • Function : Author
Maryam Ebadi
  • Function : Author
Dennis Eurich
  • Function : Author
Sascha Chopra
  • Function : Author
Dietmar Jacob
  • Function : Author
Christoph Schramm
  • Function : Author
Martina Sterneck
  • Function : Author
Tony Bruns
  • Function : Author
Philipp Reuken
  • Function : Author
Falk Rauchfuss
  • Function : Author
Davide Roccarina
  • Function : Author
Douglas Thorburn
  • Function : Author
Alessio Gerussi
  • Function : Author
Palak Trivedi
  • Function : Author
Gideon Hirschfield
  • Function : Author
Patrick Mcdowell
  • Function : Author
Frederik Nevens
  • Function : Author
Olivier Boillot
  • Function : Author
Alexie Bosch
  • Function : Author
Emiliano Giostria
  • Function : Author
Filomena Conti
  • Function : Author
Raoul Poupon
  • Function : Author
Albert Parès
  • Function : Author
Anna Reig
  • Function : Author
Maria Francesca Donato
  • Function : Author
Federica Malinverno
  • Function : Author
Annarosa Floreani
  • Function : Author
Francesco Paolo Russo
  • Function : Author
Nora Cazzagon
  • Function : Author
Xavier Verhelst
  • Function : Author
Jorn Goet
  • Function : Author
Maren H. Harms
  • Function : Author
Henk R Van Buuren
  • Function : Author
Bettina E Hansen
  • Function : Author
Fabrice Carrat
  • Function : Author
Jérôme Dumortier

Abstract

Background & Aims Recurrence of primary biliary cholangitis (PBC) after liver transplantation (LT) is frequent and able to impair graft and patient survival. Ursodeoxycholic acid (UDCA) is the current standard therapy for PBC. We investigated the effect of preventive exposure to UDCA on the incidence and long-term consequences of PBC recurrence after LT.Methods We did a retrospective cohort study including 859 patients transplanted for PBC from 1983 to 2017 in 16 centers and 9 countries and followed-up for a median time of 10 years. Among them, 204 received UDCA (10-15 mg/kg/d) preventively. The primary outcome was PBC recurrence as proven by histology. The secondary outcomes were graft loss, liver-related death, and all-cause death. The association between preventive UDCA and outcomes was quantified using multivariable-adjusted Cox proportional-hazards models.ResultsWhile recurrence of PBC significantly shortened graft and patient survivals, preventive exposure to UDCA was associated with reduced risk for PBC recurrence (adjusted hazard ratio, 0.41; 95%CI, 0.29 – 0.60; p<0.0001), graft loss (0.43; 0.20 – 0.92; p<0.05), and liver-related death (0.45; 0.21 – 0.96; p<0.05), but not all-cause death (0.85; 0.62 – 1.17). The survival gains without PBC recurrence, graft loss, or liver-related death associated with preventive UDCA were 1.43 years (95%CI, 0.82 – 2.03; p<0.0001) at 12 years and 3.40 years (2.18 – 4.62; p<0.0001) at 20 years. Exposure to cyclosporine rather than to tacrolimus added to the preventive effect of UDCA against PBC recurrence (p<0.0001).ConclusionsPreventive exposure to UDCA after LT for PBC is associated with reduced risk for PBC recurrence, graft loss, and liver-related death. Regimen combining cyclosporine, as opposed to tacrolimus, and preventive UDCA is associated with the lowest risk of PBC recurrence.
Fichier principal
Vignette du fichier
JHEPAT-S-19-03126-3.pdf (2.64 Mo) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03972698 , version 1 (03-02-2023)

Identifiers

  • HAL Id : hal-03972698 , version 1

Cite

Christophe Corpechot, Olivier Chazouillères, Pierre Belnou, Aldo J Montano-Loza, Andrew L Mason, et al.. Preventive Administration of Ursodeoxycholic Acid after Liver Transplantation for Primary Biliary Cholangitis Prevents Disease Recurrence and Prolongs Graft Survival. Journal of Hepatology, 2020. ⟨hal-03972698⟩
25 View
21 Download

Share

Gmail Mastodon Facebook X LinkedIn More